Yuyu Pharma Inc (000227) — Cash Flow Reinvestment Rate

Latest as of September 2025: 1.77x

Yuyu Pharma Inc (000227) has a Cash Flow Reinvestment Rate of 1.77x as of September 2025, reinvesting ₩1.48 Billion (capex ₩1.46 Billion plus investments ₩-22.80 Million) from operating cash flow of ₩836.62 Million. Check Yuyu Pharma Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

1.77x
(Capex + Investments) / Operating CF

Total Reinvested

₩1.48 Billion
Capex + Investments

Operating Cash Flow

₩836.62 Million
KRW

Capital Expenditures

₩1.46 Billion
KRW

Yuyu Pharma Inc Cash Flow Reinvestment Rate (2014–2024)

Historical reinvestment intensity for Yuyu Pharma Inc across 8 annual periods. Explore Yuyu Pharma Inc (000227) long-term investment share to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Yuyu Pharma Inc (2014–2024)

Year-by-year capital reinvestment analysis for Yuyu Pharma Inc. For live market cap and broader valuation context, see Yuyu Pharma Inc stock valuation.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2024 0.37x ₩9.30 Billion ₩24.95 Billion ₩7.30 Billion ▼ -97.9%
2023 17.93x ₩7.55 Billion ₩420.86 Million ₩5.11 Billion ▲ +1205.4%
2021 1.37x ₩6.19 Billion ₩4.51 Billion ₩6.07 Billion ▲ +108.6%
2019 0.66x ₩8.68 Billion ₩13.19 Billion ₩8.06 Billion ▼ -59.2%
2018 1.61x ₩9.87 Billion ₩6.11 Billion ₩9.76 Billion ▼ -83.4%
2017 9.74x ₩5.46 Billion ₩561.35 Million ₩5.19 Billion ▲ +2433.5%
2016 0.38x ₩3.77 Billion ₩9.82 Billion ₩2.32 Billion ▼ -80.8%
2014 2.00x ₩2.73 Billion ₩1.36 Billion ₩404.37 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow